Procedure code: 96372 Drug code: J1071 (Testosterone cypionate) Diagnosis code: E29.1 (Testicular hypofunction) These examples show how 96372 pairs with appropriate drug and diagnosis codes for clean, accurate billing
One commonly cited formulation lists 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157, and 10 mg TB-500 per vial , for a total of 80 mg , with GHK-Cu accounting for 62.5% of the blend and each of the other three peptides contributing 12.5% by mass, according to Protide Healths KLOW peptide guide
Reported Research Benefits Primarily used in preclinical research for topical skin rejuvenation, anti-aging effects, improving skin elasticity, collagen synthesis, and hair follicle stimulation to support hair growth and reduce hair loss
Direct delivery into circulation allows the peptide to reach target tissues without the absorption loss associated with oral forms
GT-activated prodrugs and potential nephrotoxicity Gamma-glutamyl transferase being the initial and limiting step in GT-activated prodrugs processing and because GT is highly expressed on the luminal surface of the proximal tubules in the kidney, potential nephrotoxicity could have been a limitation in the usage of this class of compound when administered systematically